Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
Lopez, Anna Lena
Anh, Dang Duc
Tapia, Milagritos D.
Grais, Rebecca F.
PublisherTaylor & Francis
MetadataShow full item record
AbstractThere are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare then with Rotarix and Rotateq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.
DescriptionPublished online: Dec. 21, 2017; Published in print: Feb. 2018
CitationDeen J, Lopez AL, Kanungo S, Wang X-Y, Anh DD, Tapia M, Grais RF. (2018). Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? Human Vaccines & Immunotherapeutics, 14(2), 495-499
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/8151
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/